Masters of Longevity - The Pulse

Nature - Biotechnology23 Jul 2026
AIIntegrated experimental and computational characterization of bioactive metabolites from Streptomyces paradoxus GH53 with antimicrobial, antioxidant, and antitu

Integrated experimental and computational characterization of bioactive metabolites from Streptomyces paradoxus GH53 with antimicrobial, antioxidant, and antitumor activities

A multidisciplinary research article examining chemical and computational approaches to characterize microbial metabolites, highlighting their potential biological activities.

Key takeaways
  • Please note there may be errors present which affect the content, and all legal disclaimers apply.
  • Fermentation conditions were optimized to enhance metabolite production.
  • Analytical profile suggested the presence of a chemically complex mixture containing fatty acids.
Fight Aging!22 Jul 2026
AIQuantifying the Risk of Alzheimer's Disease Associated with High Levels of p-tau217 in Blood (Fight Aging!)

Quantifying the Risk of Alzheimer's Disease Associated with High Levels of p-tau217 in Blood

Assessment of plasma p-tau217 as a long-term prognostic biomarker for progression from cognitive normality to clinical impairment.

Key takeaways
  • One such marker is phosphorylated tau 217 (p-tau217).
  • As the mechanisms of neurodegeneration are already operating at a higher than average level in their brain cells.
  • Tau becomes pathological and damaging when it is hyperphosphorylated.
MoL Event Pick
Longevity Wellness Expo 2026 (Toronto, Canada)

Longevity Wellness Expo 2026

2. OCT 2026 - 4. OCT 2026 - Toronto, CanadaExpo

Toronto expo and conference focused on longevity, wellness, biohacking, health optimization and healthy aging products and services.

Nature - Biotechnology23 Jul 2026
A novel small molecule remyelination therapy for multiple sclerosis (Nature - Biotechnology)

A novel small molecule remyelination therapy for multiple sclerosis

A research article describing a preclinical drug-discovery study that screened CNS-focused compounds and followed a lead through cellular and mouse remyelination assays.

Key takeaways
  • In terms of pharmacokinetics, CN045 is CNS-penetrable with low cytotoxicity.
  • CN045 has a short half-life in vivo.
  • Is an inflammatory-mediated demyelinating disease of the central nervous system (CNS).
Neuroscience News22 Jul 2026
Focused Ultrasound Delivers miRNA to Treat Glioblastoma (Neuroscience News)

Focused Ultrasound Delivers miRNA to Treat Glioblastoma

A news feature on a noninvasive MRI-guided focused ultrasound method for delivering RNA therapies into brain tumors, outlining the research approach and potential applications.

Key takeaways
  • New study utilizes MRI-guided focused ultrasound and microbubbles to open the blood-brain barrier non-invasively.
  • Approach could overcome many of the limitations of treatments using existing drugs.
  • Neuroscience News “This new approach could help target numerous molecules that promote cancer growth.